Trial Profile
Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes to Manage Post-Antibiotic Colonization and Infection With Clostridium Difficile
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Recombinant lactoferrin (Primary)
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 12 Jun 2014 New trial record